Cell-Mediated Therapies to Facilitate Operational Tolerance in Liver Transplantation
Overview
Chemistry
Molecular Biology
Affiliations
Cell therapies using immune cells or non-parenchymal cells of the liver have emerged as potential treatments to facilitate immunosuppression withdrawal and to induce operational tolerance in liver transplant (LT) recipients. Recent pre-clinical and clinical trials of cellular therapies including regulatory T cells, regulatory dendritic cells, and mesenchymal cells have shown promising results. Here we briefly summarize current concepts of cellular therapy for induction of operational tolerance in LT recipients.
Park S, Choi G Korean J Transplant. 2023; 37(4):286-292.
PMID: 38153255 PMC: 10772272. DOI: 10.4285/kjt.23.0066.
Role of Kupffer cells in tolerance induction after liver transplantation.
Zheng W, Yang L, Jiang S, Chen M, Li J, Liu Z Front Cell Dev Biol. 2023; 11:1179077.
PMID: 37601106 PMC: 10435084. DOI: 10.3389/fcell.2023.1179077.
Cell transplantation-based regenerative medicine in liver diseases.
Cardinale V, Lanthier N, Baptista P, Carpino G, Carnevale G, Orlando G Stem Cell Reports. 2023; 18(8):1555-1572.
PMID: 37557073 PMC: 10444572. DOI: 10.1016/j.stemcr.2023.06.005.